Nyheder - Meabco.dk

×

Forside
Produktudvikling
Om os
Nyheder
English

Forside
Produktudvikling
Om os
Nyheder
English

Nyheder

ARTICLE: Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study
- sep 15, 2017
- By Meabco
- In Nyheder
Breast Cancer – Targets and Therapy 2019:11 A major improvement in the prognosis of breast cancer has occurred during the…
Read More

Virksomhedsadresse

Richard Mortensens Vej 61
DK-2300 København

Kontaktoplysninger

Telefon: +45 32 46 03 70
E-mail: info@meabco.com

Seneste nyheder

ARTICLE: Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study

Powered by ATAK